---
title: "AltaValve granted US FDA breakthrough device designation"
date: "2024-05-09T08:51:14.000Z"
publishedDate: "9 mai 2024"
summary: "4C Medical Technologies has been granted breakthrough device designation by the US Food and Drug Administration (FDA) for the AltaValve system, a transcatheter mitral valve replacement (TMVR) device. Breakthrough device designation expedites the review process, shortening the time until technology reaches patients if approved by the FDA."
importance: ""
sourceUrl: "https://cardiovascularnews.com/altavalve-us-fda-breakthrough-device-designation/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2024-05-09-altavalve-granted-us-fda-breakthrough-device-designation"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2024/05/4C_Medical_Technologies_Inc_picture_1.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/altavalve-us-fda-breakthrough-device-designation/"
---

![AltaValve granted US FDA breakthrough device designation](https://cardiovascularnews.com/wp-content/uploads/sites/14/2024/05/4C_Medical_Technologies_Inc_picture_1.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/altavalve-us-fda-breakthrough-device-designation/*

## L’essentiel

4C Medical Technologies has been granted breakthrough device designation by the US Food and Drug Administration (FDA) for the AltaValve system, a transcatheter mitral valve replacement (TMVR) device. Breakthrough device designation expedites the review process, shortening the time until technology reaches patients if approved by the FDA.

## Lien source

https://cardiovascularnews.com/altavalve-us-fda-breakthrough-device-designation/
